Profile data is unavailable for this security.
About the company
Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a Hong Kong-based investment holding company principally engaged in the manufacturing and sales of pharmaceutical preparations and medical devices. The Company is principally engaged in manufacturing and sales of pharmaceutical preparations and medical devices, bio-technology products, nutrition products, specialized pharmaceutical raw materials and other products. The main products of the Company cover the anti-tumor, cardiovascular emergency pharmaceutical products and advanced cerebro-cardiovascular intervention advanced medical devices, anti-virus and anti-infection, respiratory and ear-nose-throat (ENT), bio-health products and specialized pharmaceutical ingredients.
- Revenue in HKD (TTM)10.59bn
- Net income in HKD2.41bn
- Incorporated1995
- Employees10.78k
- LocationGrand Pharmaceutical Group LtdUnits 3302The Center, 99 Queen's Road Central Hong KongHKG
- Phone+852 28663718
- Fax+852 28662521
- Websitehttp://chinagrandpharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Biostar Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 10.37bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 103.03 | -- | -18.15 | -- | -- | -- |
| Luye Pharma Group Ltd | 6.81bn | 830.46m | 10.50bn | 5.23k | 12.64 | 0.7479 | 6.28 | 1.54 | 0.2208 | 0.2208 | 1.81 | 3.73 | 0.236 | 2.44 | 3.02 | 1,291,299.00 | 3.11 | 2.80 | 5.47 | 4.45 | 68.73 | 70.53 | 13.18 | 10.39 | 1.20 | 3.14 | 0.4103 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
| Shanghai Henlius Biotech Inc | 6.08bn | 746.25m | 11.14bn | 3.55k | 14.97 | 4.01 | 9.74 | 1.83 | 1.37 | 1.37 | 11.14 | 5.11 | 0.5764 | 1.90 | 6.82 | 1,671,636.00 | 7.07 | -8.59 | 14.25 | -14.14 | 73.23 | 71.77 | 12.27 | -27.37 | 0.329 | 7.60 | 0.6113 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
| SSY Group Ltd | 6.47bn | 1.37bn | 11.45bn | 5.80k | 8.43 | 1.58 | 6.26 | 1.77 | 0.4593 | 0.4593 | 2.18 | 2.44 | 0.5418 | 2.75 | 3.07 | 1,155,141.00 | 11.54 | 10.51 | 14.88 | 14.03 | 54.39 | 58.72 | 21.30 | 18.62 | 2.06 | 28.65 | 0.323 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
| China Traditional Chinese Med Hldg CoLtd | 18.54bn | 988.87m | 11.78bn | 17.72k | 11.92 | 0.5116 | 5.23 | 0.6355 | 0.1964 | 0.1964 | 3.68 | 4.57 | 0.453 | 1.54 | 1.82 | 1,071,720.00 | 2.62 | 4.60 | 4.01 | 7.07 | 49.86 | 57.07 | 5.77 | 9.77 | 1.51 | 7.39 | 0.1808 | 17.35 | 26.69 | 9.99 | 68.11 | -2.24 | -12.75 | -- |
| Everest Medicines Ltd | 451.14m | -1.14bn | 11.81bn | 520.00 | -- | 2.45 | -- | 26.19 | -3.52 | -3.52 | 1.40 | 14.82 | 0.0756 | 5.23 | 3.22 | 1,044,315.00 | -19.03 | -30.52 | -20.21 | -33.14 | 75.74 | -- | -251.64 | -5,745.25 | 4.62 | -- | 0.1119 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
| 3SBio Inc | 9.08bn | 1.79bn | 13.99bn | 5.61k | 7.96 | 0.9023 | 6.31 | 1.54 | 0.7339 | 0.7339 | 3.73 | 6.47 | 0.3575 | 1.52 | 6.87 | 1,677,561.00 | 7.25 | 7.44 | 10.26 | 9.29 | 85.94 | 82.91 | 20.27 | 21.50 | 1.57 | 141.55 | 0.1998 | -- | 13.84 | 11.26 | -19.13 | 3.94 | 8.78 | -- |
| Simcere Pharmaceutical Group Ltd | 6.84bn | -1.19bn | 16.47bn | 6.41k | -- | 2.23 | -- | 2.41 | -0.4543 | -0.4543 | 2.65 | 2.93 | 0.5198 | 2.19 | 2.64 | 972,792.20 | -9.04 | 10.17 | -11.71 | 15.60 | 77.02 | 78.82 | -17.40 | 17.50 | 1.88 | 0.4721 | 0.1461 | 46.68 | 4.49 | 7.92 | -23.22 | -0.5213 | 23.93 | -- |
| Grand Pharmaceutical Group Ltd | 10.59bn | 2.41bn | 17.32bn | 10.78k | 7.09 | 1.10 | 6.02 | 1.64 | 0.6885 | 0.6885 | 3.03 | 4.43 | 0.4472 | 3.62 | 4.54 | 1,005,064.00 | 10.25 | 10.09 | 14.21 | 14.01 | 59.00 | 61.97 | 22.92 | 22.35 | 1.09 | -- | 0.2232 | 26.94 | 10.12 | 12.06 | -9.59 | 21.41 | 5.69 | 24.77 |
| The United Laboratories Intl. Hldgs Ltd. | 15.10bn | 3.13bn | 18.42bn | 15.00k | 5.88 | 1.26 | 4.92 | 1.22 | 1.73 | 1.73 | 8.31 | 8.02 | 0.6578 | 3.30 | 5.67 | 1,006,664.00 | 13.65 | 7.89 | 20.72 | 12.64 | 46.15 | 44.17 | 20.75 | 12.73 | 1.72 | -- | 0.1532 | 28.99 | 21.22 | 12.84 | 70.85 | 31.66 | 24.19 | 46.04 |
| China Medical System Holdings Ltd | 7.56bn | 1.50bn | 18.76bn | 5.78k | 12.54 | 1.08 | 10.80 | 2.48 | 0.6134 | 0.6134 | 3.09 | 7.10 | 0.384 | 2.89 | 5.65 | 1,326,150.00 | 7.51 | 18.44 | 8.53 | 21.14 | 74.13 | 75.47 | 19.56 | 34.26 | 3.97 | -- | 0.0667 | 40.14 | -12.43 | 8.08 | -26.33 | 5.35 | 38.69 | 5.19 |
| HUTCHMED (China) Ltd | 4.75bn | -326.34m | 24.14bn | 1.97k | -- | 4.19 | -- | 5.08 | -0.3883 | -0.3883 | 5.51 | 6.60 | 0.4775 | 7.10 | 4.15 | 2,389,026.00 | -3.30 | -14.35 | -4.65 | -20.43 | 41.67 | 36.57 | -6.91 | -31.44 | 2.68 | -- | 0.0984 | -- | 96.52 | 31.38 | 127.93 | -- | 38.65 | -- |
| Zai Lab Ltd | 2.51bn | -2.32bn | 24.35bn | 2.18k | -- | 4.38 | -- | 9.71 | -2.39 | -2.39 | 2.58 | 5.58 | 0.3083 | 3.04 | 5.52 | -- | -28.50 | -37.72 | -34.92 | -42.72 | 63.17 | 64.75 | -92.44 | -282.44 | 3.29 | -- | 0.0908 | -- | 24.03 | 360.03 | 24.51 | -- | -3.45 | -- |
Data as of Nov 13 2024. Currency figures normalised to Grand Pharmaceutical Group Ltd's reporting currency: Hong Kong Dollar HKD
3.94%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 02 Oct 2024 | 51.24m | 1.44% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 26.06m | 0.73% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 21.84m | 0.62% |
| BlackRock Fund Advisorsas of 03 Oct 2024 | 16.63m | 0.47% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 10.32m | 0.29% |
| BlackRock Advisors (UK) Ltd.as of 03 Oct 2024 | 3.96m | 0.11% |
| American Century Investment Management, Inc.as of 31 Oct 2024 | 2.79m | 0.08% |
| SSgA Funds Management, Inc.as of 03 Oct 2024 | 2.48m | 0.07% |
| Principal Global Investors LLCas of 30 Jun 2024 | 2.37m | 0.07% |
| Principal Global Investors (Hong Kong) Ltd.as of 30 Jun 2024 | 2.01m | 0.06% |
More ▼
Data from 30 Jun 2024 - 29 Oct 2024Source: FactSet Research Systems Inc.
